[1]
|
Crawford, D.H. (2001) Biology and Disease Associations of Epstein-Barr Virus. Philosophical Transactions of the Royal Society B: Biological Science, 356, 461-473. http://dx.doi.org/10.1098/rstb.2000.0783
|
[2]
|
Kieff, E. and Rickinson, A.B. (2001) In: Knipe, D.M., Howley, P.M. and Griffin, D.E., Eds., Fields Virology, Lippincott Williams & Wilkins, Philadelphia, 2511-2573.
|
[3]
|
Wilson, J.B., Weinberg, W., Johnson, R., Yuspa, S. and Levine, A.J. (1990) Expression of the BNLF-1 Oncogene of Epstein-Barr Virus in the Skin of Transgenic Miceinduces Hyperplasia and Aberrant Expression of Keratin 6. Cell, 61, 1315-1327. http://dx.doi.org/10.1016/0092-8674(90)90695-B
|
[4]
|
Kulwichit, W., Edwards, R.H., Davenport, E.M., Baskar, J.F., Godfrey, V. and Raab-Traub, N. (1998) Expression of the Epstein-Barr Virus Latent Membrane Protein 1 Induces B Cell Lymphoma in Transgenic Mice. Proceedings of the National Academy of Sciences of the United States of America, 95, 11963-11968. http://dx.doi.org/10.1073/pnas.95.20.11963
|
[5]
|
Stevenson, D., Charalambous, C. and Wilson, J.B. (2005) Epstein-Barr Virus Latent Membrane Protein 1 (CAO) Up-Regulates VEGF and TGFa Concomitant with Hyperlasia, with Subsequent Up-Regulation of p16 and MMP9. Cancer Research, 65, 8826-8835. http://dx.doi.org/10.1158/0008-5472.CAN-05-0591
|
[6]
|
Young, L.S. and Murray, P.G. (2003) Epstein-Barr Virus and Oncogenesis: From Latent Genes to Tumours. Oncogene, 22, 5108-5121. http://dx.doi.org/10.1038/sj.onc.1206556
|
[7]
|
Shair, K.H., Bendt, K.M., Edwards, R.H., Bedford, E.C., Nielsen, J.N. and Raab-Traub, N. (2007) EBV Latent Membrane Protein 1 Activates Akt, NFkappaB, and Stat3 in B cell Lymphomas. PLOS Pathogens, 3, e166. http://dx.doi.org/10.1371/journal.ppat.0030166
|
[8]
|
Ferlay, J., Shin, H.R. and Bray, F. (2008) Estimates of Worldwide Burden of Cancer in 2008: GLOBOCAN 2008. International Journal of Cancer, 127, 2893-2917. http://dx.doi.org/10.1002/ijc.25516
|
[9]
|
Gaidano, G., Pastore, C. and Volpe, G. (1995) Molecular Pathogenesis of Non-Hodgkin Lymphoma: A Clinical Perspective. Haematologica, 80, 454-472.
|
[10]
|
Grulich, A.E., Vajdic, C.M. and Cozen, W. (2007) Altered Immunity as a Risk Factor for Non-Hodgkin Lymphoma. Cancer Epidemiology, Biomarkers & Prevention, 16, 405-408.
|
[11]
|
Vrzalikova, K., Vockerodt, M., Leonard, S., Bell, A., Wei, W., Schrader, A., Wright, K.L., Kube, D., Rowe, M., Woodman, C.B. and Murray, P.G. (2011) Down-Regulation of BLIMP1α by the EBV Oncogene, LMP-1, Disrupts the Plasma Cell Differentiation Program and Prevents Viral Replication in B Cells: Implications for the Pathogenesis of EBV-Associated B-Cell Lymphomas. Blood, 117, 5907-5917. http://dx.doi.org/10.1182/blood-2010-09-307710
|
[12]
|
Mei, Y.P., Zhou, J.M., Wang, Y., Huang, H., et al. (2007) Silencing of LMP1 Induces Cell Cycle Arrest and Enhances Chemosensitivity through Inhibition of AKT Signaling Pathway in EBV Positive Nasopharyngeal Carcinoma Cells. Cell Cycle, 6, 1379-1385. http://dx.doi.org/10.4161/cc.6.11.4274
|
[13]
|
Khabir, A., Karray, H., Rodriguez, S., Rosé, M., Daoud, J., Frikha, M., Boudawara, T., Middeldorp, J., Jlidi, R. and Busson, P. (2005) EBV Latent Membrane Protein 1 Abundance Correlates with Patient Age but Not with Metastatic Behavior in North African Nasopharyngeal Carcinomas. Virology Journal, 2, 39. http://dx.doi.org/10.1186/1743-422X-2-39
|
[14]
|
Nourse, J.P., Crooks, P., Keane, C., Nguyen-Van, D., Mujaj, S., Ross, N., Jones, K., Vari, F., Han, E., Trappe, R., Fink, S. and Gandhi, M.K. (2012) Expression Profiling of Epstein-Barr Virus-Encoded microRNAs from Paraffin-Embedded Formalin-Fixed Primary Epstein-Barr Virus-Positive B-Cell Lymphoma Samples. Journal of Virological Methods, 184, 46-54. http://dx.doi.org/10.1016/j.jviromet.2012.05.005
|
[15]
|
Omoti, C.E., Nwannadi, A.I., Obieche, J.C. and Olu-Eddo, A.N. (2012) The Epidemiological Features of Lymphoid Malignancies in Benin City, Nigeria: A 15 Years Study. The Pan African Medical Journal, 11, 10.
|
[16]
|
Ishtiaq, S., Hassan, U., Mushtaq, S. and Akhtar, N. (2013) Determination of Frequency of Epstein-Barr Virus in Non-Hodgkin Lymphomas Using EBV Latent Membrane Protein 1 (EBV-LMP1) Immunohistochemical Staining. Asian Pacific Journal of Cancer Prevention, 14, 3963-3967. http://dx.doi.org/10.7314/APJCP.2013.14.6.3963
|
[17]
|
Gonin, J., Larousserie, F., Bastard, C., Picquenot, J.-M., Couturier, J., Radford-Weiss, I., Dietrich, C., et al. (2011) Epstein-Barr Virus-Induced Gene 3 (EBI3): A Novel Diagnosis Marker in Burkitt Lymphoma and Diffuse Large B-Cell Lymphoma. PLoS ONE, 6, e24617. http://dx.doi.org/10.1371/journal.pone.0024617
|
[18]
|
Oyama, T., Yamamoto, K., Asano, N., Oshiro, A., Suzuki, R., Kagami, Y., Morishima, Y., Takeuchi, K., Izumo, T., Mori, S., Ohshima, K., Suzumiya, J., Nakamura, N., et al. (2007) Age-Related EBV Associated B-Cell Lymphoproliferative Disorders Constitute a Distinct Clinicopathologic Group: A Study of 96 Patients. Clinical Cancer Research, 13, 5124-5132. http://dx.doi.org/10.1158/1078-0432.CCR-06-2823
|
[19]
|
Morales, D., Beltran, B., De Mendoza, F.H., Riva, L., Yabar, A., Quinones, P., Butera, J.N. and Castillo, J. (2010) Epstein-Barr Virus as a Prognostic Factor in de Novo Nodal Diffuse Large B-Cell Lymphoma. Leukemia & Lymphoma, 51, 66-72. http://dx.doi.org/10.3109/10428190903308015
|
[20]
|
Park, S., Lee, J., Ko, Y.H., Han, A., Jun, H.J., Lee, S.C., Hwang, I.G., Park, Y.H., Ahn, J.S., Jung, C.W., Kim, K., Ahn, Y.C., Kang, W.K., Park, K. and Kim, W.S. (2007) The Impact of Epstein-Barr Virus Status on Clinical Outcome in Diffuse Large B-Cell Lymphoma. Blood, 110, 972-978. http://dx.doi.org/10.1182/blood-2007-01-067769
|
[21]
|
Adam, P., Bonzheim, I., Fend, F. and Quintanilla-Martínez, L. (2011) Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphomas of the Elderly. Advances in Anatomic Pathology, 18, 349-355. http://dx.doi.org/10.1097/PAP.0b013e318229bf08
|
[22]
|
Tumwine, L.K., Orem, J., Kerchan, P., Byarugaba, W. and Pileri, S.A. (2010) EBV, HHV8 and HIV in B Cell Non Hodgkin Lymphoma in Kampala, Uganda. Infectious Agents and Cancer, 5, 12. http://dx.doi.org/10.1186/1750-9378-5-12
|
[23]
|
Osman, I.M., Mohamadani, A. and Mohamed Kheir, S. (2014) Non-Hodgkin Lymphoma in Sudanese Children. Sudan Journal of Medical Sciences, 9, 31-38.
|
[24]
|
Mao, Y., Zhang, D.-W., Zhu, H., Lin, H., Xiong, L., Cao, Q., Liu, Y., Li, Q.-D., Xu, J.-R., Xu, L.-F. and Chen, R.-J. (2012) LMP1 and LMP2A Are Potential Prognostic Markers of Extranodal NK/T-Cell Lymphoma, Nasal Type (ENKTL). Diagnostic Pathology, 7, 178. http://dx.doi.org/10.1186/1746-1596-7-178
|
[25]
|
Horikawa, T., Yoshizaki, T., Sheen, T.-S., Lee, S.-Y. and Furukawa, M. (2000) Association of Latent Membrane Protein 1 and Matrix Metalloproteinase 9 with Metastasis in Nasopharyngeal Carcinoma. Cancer, 89, 715-723. http://dx.doi.org/10.1002/1097-0142(20000815)89:4<715::aid-cncr1>3.0.co;2-9
|